vs
Side-by-side financial comparison of CLOVER HEALTH INVESTMENTS, CORP. (CLOV) and Enpro Inc. (NPO). Click either name above to swap in a different company.
CLOVER HEALTH INVESTMENTS, CORP. is the larger business by last-quarter revenue ($487.7M vs $295.4M, roughly 1.7× Enpro Inc.). CLOVER HEALTH INVESTMENTS, CORP. runs the higher net margin — -10.1% vs -10.8%, a 0.7% gap on every dollar of revenue. On growth, CLOVER HEALTH INVESTMENTS, CORP. posted the faster year-over-year revenue change (44.7% vs 14.3%). Over the past eight quarters, CLOVER HEALTH INVESTMENTS, CORP.'s revenue compounded faster (18.6% CAGR vs 7.1%).
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage (MA) insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021.
Enpro is a US-based industrial technology company that designs and manufactures products and materials for technology-intensive sectors. The company serves industries such as semiconductors, aerospace, power generation, heavy-duty trucking, agricultural machinery, chemical processing, pulp and paper, and life sciences from 61 primary manufacturing facilities located in 12 countries, worldwide. It is organized under three segments: Sealing Technologies, Advanced Surface Technologies, and Engin...
CLOV vs NPO — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $487.7M | $295.4M |
| Net Profit | $-49.3M | $-32.0M |
| Gross Margin | — | 42.1% |
| Operating Margin | -10.1% | 11.2% |
| Net Margin | -10.1% | -10.8% |
| Revenue YoY | 44.7% | 14.3% |
| Net Profit YoY | -123.2% | -330.2% |
| EPS (diluted) | — | $-1.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $487.7M | $295.4M | ||
| Q3 25 | $496.6M | $286.6M | ||
| Q2 25 | $477.6M | $288.1M | ||
| Q1 25 | $462.3M | $273.2M | ||
| Q4 24 | $337.0M | $258.4M | ||
| Q3 24 | $331.0M | $260.9M | ||
| Q2 24 | $356.3M | $271.9M | ||
| Q1 24 | $346.9M | $257.5M |
| Q4 25 | $-49.3M | $-32.0M | ||
| Q3 25 | $-24.4M | $21.6M | ||
| Q2 25 | $-10.6M | $26.4M | ||
| Q1 25 | $-1.3M | $24.5M | ||
| Q4 24 | $-22.1M | $13.9M | ||
| Q3 24 | $-9.2M | $19.8M | ||
| Q2 24 | $7.4M | $26.7M | ||
| Q1 24 | $-19.2M | $12.5M |
| Q4 25 | — | 42.1% | ||
| Q3 25 | — | 41.9% | ||
| Q2 25 | — | 43.3% | ||
| Q1 25 | — | 43.3% | ||
| Q4 24 | — | 42.3% | ||
| Q3 24 | 24.5% | 42.3% | ||
| Q2 24 | 30.3% | 43.8% | ||
| Q1 24 | 23.6% | 41.2% |
| Q4 25 | -10.1% | 11.2% | ||
| Q3 25 | -4.9% | 14.3% | ||
| Q2 25 | -2.2% | 15.9% | ||
| Q1 25 | -0.3% | 15.3% | ||
| Q4 24 | -6.4% | 12.5% | ||
| Q3 24 | -2.7% | 13.1% | ||
| Q2 24 | 2.0% | 17.7% | ||
| Q1 24 | -6.5% | 10.9% |
| Q4 25 | -10.1% | -10.8% | ||
| Q3 25 | -4.9% | 7.5% | ||
| Q2 25 | -2.2% | 9.2% | ||
| Q1 25 | -0.3% | 9.0% | ||
| Q4 24 | -6.6% | 5.4% | ||
| Q3 24 | -2.8% | 7.6% | ||
| Q2 24 | 2.1% | 9.8% | ||
| Q1 24 | -5.5% | 4.9% |
| Q4 25 | — | $-1.50 | ||
| Q3 25 | — | $1.01 | ||
| Q2 25 | — | $1.25 | ||
| Q1 25 | — | $1.15 | ||
| Q4 24 | — | $0.65 | ||
| Q3 24 | — | $0.94 | ||
| Q2 24 | — | $1.27 | ||
| Q1 24 | — | $0.59 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $78.3M | $114.7M |
| Total DebtLower is stronger | — | $655.3M |
| Stockholders' EquityBook value | $308.7M | $1.5B |
| Total Assets | $541.0M | $2.7B |
| Debt / EquityLower = less leverage | — | 0.42× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $78.3M | $114.7M | ||
| Q3 25 | — | $132.9M | ||
| Q2 25 | — | $107.1M | ||
| Q1 25 | — | $240.3M | ||
| Q4 24 | $194.5M | $236.3M | ||
| Q3 24 | $288.0M | $206.9M | ||
| Q2 24 | $254.8M | $175.9M | ||
| Q1 24 | $208.3M | $163.9M |
| Q4 25 | — | $655.3M | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | $640.1M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $644.9M |
| Q4 25 | $308.7M | $1.5B | ||
| Q3 25 | $340.9M | $1.5B | ||
| Q2 25 | $344.2M | $1.5B | ||
| Q1 25 | $336.1M | $1.5B | ||
| Q4 24 | $341.1M | $1.4B | ||
| Q3 24 | $342.2M | $1.5B | ||
| Q2 24 | $324.9M | $1.4B | ||
| Q1 24 | $292.5M | $1.4B |
| Q4 25 | $541.0M | $2.7B | ||
| Q3 25 | $559.7M | $2.4B | ||
| Q2 25 | $575.0M | $2.4B | ||
| Q1 25 | $583.7M | $2.5B | ||
| Q4 24 | $580.7M | $2.5B | ||
| Q3 24 | $653.0M | $2.5B | ||
| Q2 24 | $674.2M | $2.5B | ||
| Q1 24 | $671.8M | $2.5B |
| Q4 25 | — | 0.42× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | 0.45× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.46× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-66.9M | — |
| Free Cash FlowOCF − Capex | $-69.0M | — |
| FCF MarginFCF / Revenue | -14.1% | — |
| Capex IntensityCapex / Revenue | 0.4% | 4.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-69.2M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-66.9M | — | ||
| Q3 25 | $12.1M | $65.3M | ||
| Q2 25 | $5.4M | $52.2M | ||
| Q1 25 | $-16.3M | $21.0M | ||
| Q4 24 | $34.8M | $59.4M | ||
| Q3 24 | $50.0M | $54.0M | ||
| Q2 24 | $44.8M | $43.2M | ||
| Q1 24 | $25.9M | $6.3M |
| Q4 25 | $-69.0M | — | ||
| Q3 25 | $11.4M | $53.4M | ||
| Q2 25 | $4.8M | $42.3M | ||
| Q1 25 | $-16.5M | $13.0M | ||
| Q4 24 | $33.3M | $49.1M | ||
| Q3 24 | $49.6M | $48.3M | ||
| Q2 24 | $44.4M | $38.3M | ||
| Q1 24 | $25.5M | $-1.9M |
| Q4 25 | -14.1% | — | ||
| Q3 25 | 2.3% | 18.6% | ||
| Q2 25 | 1.0% | 14.7% | ||
| Q1 25 | -3.6% | 4.8% | ||
| Q4 24 | 9.9% | 19.0% | ||
| Q3 24 | 15.0% | 18.5% | ||
| Q2 24 | 12.5% | 14.1% | ||
| Q1 24 | 7.3% | -0.7% |
| Q4 25 | 0.4% | 4.1% | ||
| Q3 25 | 0.1% | 4.2% | ||
| Q2 25 | 0.1% | 3.4% | ||
| Q1 25 | 0.0% | 2.9% | ||
| Q4 24 | 0.5% | 4.0% | ||
| Q3 24 | 0.1% | 2.2% | ||
| Q2 24 | 0.1% | 1.8% | ||
| Q1 24 | 0.1% | 3.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | 3.02× | ||
| Q2 25 | — | 1.98× | ||
| Q1 25 | — | 0.86× | ||
| Q4 24 | — | 4.27× | ||
| Q3 24 | — | 2.73× | ||
| Q2 24 | 6.04× | 1.62× | ||
| Q1 24 | — | 0.50× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CLOV
Segment breakdown not available.
NPO
| Sealing Technologies Segment | $187.0M | 63% |
| General Industrial | $71.3M | 24% |
| Power Generation | $19.9M | 7% |
| Oiland Gas Market | $15.0M | 5% |
| Semiconductors | $2.2M | 1% |
